| Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon (NCT00419419) | MediQuest Therapeutics | 2006-12-01 |
| Premature Coronary Atherosclerosis in Scleroderma (NCT00372398) | Tuen Mun Hospital | 2006-10-01 |
| Scleroderma Registry & Repository at the Hospital for Special Surgery (NCT01656447) | Hospital for Special Surgery, New York | 2006-08-01 |
| Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient (NCT00566137) | Northwell Health | 2006-02-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis (NCT00282425) | Richard Burt, MD | 2005-05-01 |
| Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls (NCT00213525) | University Hospital, Rouen | 2004-10-01 |
| Open-label Study With Bosentan in Interstitial Lung Disease (NCT00319033) | Actelion | 2004-07-01 |
| Effectiveness and Safety of Lidocaine for Scleroderma (NCT00740285) | Federal University of São Paulo | 2004-04-01 |
| Comparison of Esophageal and Anorectal Manometry Catheters (NCT00204763) | University of Utah | 2004-01-01 |
| Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients (NCT00040651) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2002-07-01 |
| UVA1 Light for Treatment of Scleroderma and Similar Conditions (NCT00476801) | University of Michigan | 2001-07-01 |
| Psychological Treatments for Scleroderma (NCT00007267) | Johns Hopkins University | 2001-06-01 |
| High Dose Cyclophosphamide for Treatment of Scleroderma (NCT00501995) | Johns Hopkins University | 2001-02-01 |
| Oral Type I Collagen for Relieving Scleroderma (NCT00005675) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2000-04-01 |
| Optical Biopsy of Human Skin in Conjunction With Laser Treatment (NCT00540566) | University of California, Irvine | 1999-06-01 |
| UVA1 Light for Scleroderma and Similar Conditions (NCT00476697) | University of Michigan | 1997-01-01 |
| Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis (NCT00043706) | Genzyme, a Sanofi Company | |
| Post Marketing Surveillance Study of Cuprimine (NCT01374282) | Merck Sharp & Dohme LLC | |